Iptakalim alleviated the increase of extracellular dopamine and glutamate induced by 1-methyl-4-phenylpyridinium ion in rat striatum

Neurosci Lett. 2006 Aug 14;404(1-2):187-90. doi: 10.1016/j.neulet.2006.05.042. Epub 2006 Jun 15.

Abstract

The present study examined the effect of iptakalim (Ipt), a novel ATP-sensitive potassium (K(ATP)) channel opener (KCO), on 1-methyl-4-phenylpyridinium ion (MPP(+))-induced dopamine (DA) and glutamate efflux in extracellular fluid of rat striatum, using microdialysis technique. Rats were implanted guide cannula in the striatum and artificial cerebrospinal fluid was infused through a microdialysis probe to detect the level of DA and glutamate in the striatum. MPP(+) significantly enhanced the extracellular levels of DA and its metabolites, DOPAC and HVA, as well as glutamate. Application of Ipt (1, 10, 100 microM) concentration-dependently suppressed DA and its metabolites efflux induced by MPP(+). Concomitantly, Ipt reduced the increase of extracellular glutamate induced by MPP(+). These results suggest that Ipt can regulate DA and glutamate efflux induced by MPP(+) in rat striatum.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenylpyridinium / antagonists & inhibitors
  • 1-Methyl-4-phenylpyridinium / pharmacology*
  • Animals
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism*
  • Dopamine / metabolism
  • Extracellular Space / drug effects
  • Extracellular Space / metabolism
  • Glutamic Acid / metabolism*
  • Kinetics
  • Male
  • Propylamines / pharmacology*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • N-(1-methylethyl)-1,1,2-trimethylpropylamine
  • Propylamines
  • Glutamic Acid
  • 1-Methyl-4-phenylpyridinium
  • Dopamine